Story · Medicine & Biotech

The nerve switch Sironax wants to keep switched off

1 outlet · first reported by Longevity.Technology 5d ago

Coverage, in order

  1. 5d ago
    Longevity.Technology UK indie
    The nerve switch Sironax wants to keep switched off

    SIR2501, a SARM1 blocker with FDA Fast Track status for chemo nerve damage, gets three poster slots in Washington. Sironax ’s lead drug is turning up in an odd mix of places this month: ALS, chemotherapy-related nerve damage, glaucoma and stroke. The Waltham, Massachusetts biotech has three…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.